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Abstract Background: Helicobacter 
pylori (H pylori) infection is the 
commonest global chronic human 
bacterial infection. Data from devel-
oped countries show that acquisition 
occurs in childhood but manifesta-
tion of chronic gastroduodenal dis-
eases occur more commonly in 
adulthood. H. pylori infection has 
however been associated with paedi-
atric primary peptic ulcer disease, 
though data is rather scanty. There 
is virtually no data on the clinical 
correlates of the seropositive Nige-
rian paediatric subjects though the 
little data available shows higher 
prevalence rates compared to that of 
children from developed countries.  
Objectives: A prospective observa-
tional survey was carried out to de-
termine the clinical correlates of H. 
pylori infection in ill children admit-
ted in the emergency unit of our 
department.   
Methods: H. pylori Immunoglobulin 
G antibody was determined from 
serum samples stored at -200C using 
a commercial enzyme-linked immu-
nosorbent assay kit, VicTorch. Data 
was analysed with using SPSS and 
correlates determined as appropri-
ate.  
Results: The subjects were 132
(57.4%) males and 98(42.6%) fe-
males (male: female ratio= 1.3:1.0) 
with an age range of 0.5-15 years 
and a mean age of 5.0 (SD±4.0) 
years. The overall seroprevalence 
rate was 30.9%. Clinical features 
including abdominal pains,
(p=0.001),  fetor oris, (p=0.0001), 
diarrhoea (0.041) and family history 
of dyspepsia (p=0.002), showed 
significant association with sero-
positivity.  
Conclusion: Seroprevalence of H. 
pylori  infection in Nigerian chil-
dren is high and is associated with 
common gastroduodenal symptoms. 
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Helicobacter pylori (H pylori) infection is the common-
est chronic human bacterial infection and about 50% of 
adults the world over are said to be colonised with the 
pathogen.1 The aetiologic agent is a flagellated spiral-
shaped Gram negative bacterium with its natural eco-
logical niche being the antral portion of the human 
stomach.2,3 Its colonisation of the human gastric antrum 
has been associated with chronic gastroduodenal dis-
eases worldwide. Manifestations of H. pylori associated 
gastroduodenal diseases have been reported principally 
in adulthood although the acquisition occurs in child-
hood.1 Primary peptic ulcer disease has been shown to 
be associated with H. pylori  infection in children.4 
There is a dearth of information on H. pylori associated 
clinical manifestations in children even though higher 
incidence rates are recorded in the socioeconomically-
challenged developing countries where over 50% of 
children are infected by five years of age.5-9 
The clinical course of H. pylori infection is highly vari-
able. This is influenced by the microbial, host and e vi-
ronmental factors. The dynamics of this global infection 
are different for different regions but in virtually all in-
fected individuals, H. pylori infection causes a chronic 
inflammation of the gastric mucosa. Gastritis develops 
rapidly after acquisition of H. pylori  infection and re-
mains with the persistence of the infection.10 This gastri-
tis is suggested to be a precursor of gastric cancer with 
obvious grave consequencies.11   
 
In the adult population, acute H. pylori  infection is ac-
companied by mild to moderate dyspeptic symptoms 
and occasional vomiting occurring within a few days of 
the challenge. These symptoms peak during the second 
week of illness and then resolve.12 In children, the symp-
tomatology of acute H. pylori infection is not well char-
acterised. Occasionally, acute infection may cause ga -
tric ulcers and haematemesis.13 There is virtually no data 
on clinical manifestations of H. pylori infection in  
Nigerian children though the scanty available data show 
that the prevalence of this infection is very high.5,6 In 
Maiduguri, Holcombe et al reported age specific preva-
lence rates of 82% and 92% in children aged 5-10years 
and 11-19 years respectively.5 
 
This study was therefore undertaken to see whether or 
not the high seropositivity of H. pylori  infection as  
reported in Nigerian children has any clinical correlates 
in children admitted for treatment of various ailments at 





Subjects and methods 
 
The study was conducted at the University of Uyo 
Teaching Hospital, Uyo, in Akwa Ibom State. Akwa 
Ibom State has a population of 3.9 million people.14 Uyo 
is the capital city of Akwa Ibom State. It is predomi-
nantly a civil service town. The Teaching Hospital s a 
300 bed capacity hospital and the only tertiary healt  
institution in the state.  
 
The study population consisted of 230 children, admit-
ted in the children emergency unit of our hospital, aged 
between six months and 15 years who required  
venepuncture, and for whom an informed written con-
sent was obtained. The sample size was calculated using
the formula 
         n = Z2P(1-P) 
       d2 
Where   n =   Minimum sample size 
                Z =   Standardized normal deviation (1.96) 
                P = Best estimate of population preval nce    
           rate (82%)5 
  d  =   Tolerable error margin (5%)      
The best estimate of population prevalence rate for H.  
pylori in Nigerian children = 82%.5  
  
Therefore, minimum sample size was  
         n       =       (1.96)2 × 0.82 x 0.18      =   227 
                                       (0.05)2  
A clinical history was obtained from each subject, in-
cluding the family and social history and the child’s 
socioeconomic status was determined using the parents/
guardians social class according to the social classifica-
tion scheme proposed by Oyedeji.15 A quick clinical 
examination, including oral and dental assessments, wa  
also done. Standard anthropometric measurements were 
taken. These were recorded on the study proforma. 
 
About 2.0mls of blood was collected from each subject 
into a plain specimen bottle and taken to the labortory 
within 30 minutes and centrifuged to separate the serum, 
which was stored frozen at -200C till sufficient samples 
were pooled for analysis.  
 
The VicTorch H pylori  IgG test kit, with high sensitiv-
ity and specificity of 90-93% and 95-96% respectively, 
 
 was used for the analysis as described by the manufac-
turer.16 The reagents were stored unopened at 40C.  Re-
peated freezing and thawing of the samples or microb al 
contamination were avoided and icteric or turbid sam-
ples were not used (manufacturer’s precautionary ad-
vice). The cut off value for positive antibody activity 
(AA) was taken at greater than 20IU.16 A definite infec-
tion, as determined by the antibody activity of this test 
kit, was not less than 10% of the cut off value with accu-
racy level of 85.2%.16 The test principle is based on ap-
preciation of antibody titre with time and the 20IU is the 
level at which antibody build up determined a definite 
infection in comparison with urea breath test of gastric 
biopsy specimens.  
 
 Ethical approval was given by the Ethical Committee of 




Statistical analyses were performed using the SPSS soft-
ware package (Statistical Package for Social Sciences) 
15.0 Software. Data were summarised into tables. 
The seropositivity for H. pylori was computed according 
to age. Correlates of H. pylori were evaluated by a com-
parison of proportions of children with and without in-
fection using Chi-square(x2) test and Fisher’s exact test 
as appropriate. 
 
Controlling variables for evaluation with multiple logis-
tic models were age, gender and symptoms. 
The statistical significance of the adjusted seropositive 
rates among comparison groups was also tested.  p-value 







Two hundred and thirty children aged 6 months to 15 
years with mean age of 5.0 (±4.0) years, median age of 
4.0 years, comprising 132 (57.4%) males and 98 
(42.6%) females had their serum samples tested for IgG 
antibody reaction to H. pylori.  
 
Using the cut-off value for antibody activity (AA) of 
20IU, 71 (30.9%) were serologically positive for H. py-
lori IgG antibodies while 159 (69.1%) were negative. 
The antibody activity (AA) level of seropositive chil-
dren was >20.0IU with a mean (±SD) value of 42.0IU 
(±16.1) as given by the manufacturers. 
 
The age distributions of the study subjects were as 
shown in Table 1. Children less than five years of age 
constituted 60.0% of the subjects. H. pylori seropositiv-
ity was highest in the one to five years age group 
(36.6%) and the cumulative seropositivity was  56.3% in 
the under five years age group. The least representd age 
group was 11- 15 years which constituted 12.2% of the 
study population with 9.9% seropositivity.  
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The general characteristics of the subjects namely;  
the mean age, weight, height and body mass index were  
 
 
HPAP =H. pylori Antibody Positive 
HPAN =H. pylori Antibody Negative 
 
Table 2 shows that H. pylori seropositivity was signifi-
cantly associated with abdominal pain (p=0.001, 95% 










































 AA+ = Antibody activity positive 
 AA- = Antibody activity negative 
 NK = Not known 
similar for both male and female subjects and had no 
association with H. pylori Ig G antibody activity.  
Age (years) subjects % Cumulative HPAP % Cumulative HPAN % Cumulative 
<1 30 13.0 13.0 14 19.7 19.7 16 10.1 10.1 
1-5 108 47.0 60.0 26 36.6 56.3 82 51.6 61.7 
6-10 64 27.8 87.7 24 33.8 90.1 40 25.1 86.8 
11-15 28 12.2 100 7 9.9 100 21 13.2 100 
Table 1: Distribution of subjects by age 
  
 Symptom 
All subjects H.pylori  IgG Reaction p RR 95% CI 
Positive Negative 
n (%) n (%) n (%) 
Irritability            
Yes 34 12 (35.3) 22(64.7) 0.545 1.26 0.59,2.73 
No 196 59 (30.1) 137 (69.9)       
Frequent vomiting             
Yes 123 39 (31.7) 84 (68.3) 0.768 1.09 0.62,1.91 
No 107 84(29.9.) 75 (70.1)       
Bad breath             
Yes 19 13 (68.4) 6 (31.6) 0.001 5.71 2.08,9.74 
No 211 58 (27.5) 153 (72.5)       
Blood in stool             
Yes 19 12 (35.3) 22 (64.7) 0.545 1.26 0.59,2.73 
No 196 59 (30.1) 137(69.9)       
Diarrhoea             
Yes 31 5 (16.1) 26 (83.9) 0.041 0.39 0.14,1.06 
No 199 66 (33.2) 133 (66.8)       
Family history of dyspepsia             
Yes 41 21 (51.2) 20(48.8) 0.002 2.92 1.46,5.83 
No 189 50 (26.5) 139 (73.5)       
Table 2: Relationship between clinical history, symptoms andH. pylori seropositivity 
and diarrhoea (P=0.041, 95% CI=0.14,1.06) but there 
was no association with irritability, heart burns, blood in 
stool and frequent vomiting.  
 
Table 3 shows that H. pylori seropositivity was associ-
ated with a positive family history of dyspepsia 
(p=0.002 95% CI=1.46,5.83). 
Symptom yes   No   NK       
  AA+ AA-  AA+ AA-  AA+ AA-  p 95% CI 
Abdominal pain             0.001 1.42.4.59 
≤5years 0 0 0 1 39 98     
6-10 years 17 18 5 14 2 8     
11-15years 2 9 4 5 1 7     
Heart burns             0.24 1.079,1.691 
≤5 years 0 0 0 0 40 98     
6-10years 10 21 9 7 5 12     
11-15years 2 8 1 5 1 15     
Infantile colic             0.058 1.432,1.657 
<1 years 8 20 2 5 4 15     
1-5years 7 20 8 39 11 23     
6-10years 5 7 7 13 22 20     
11-15years 1 4 1 5 8 9     
Table 3: Relationship between some symptoms and H. pylori seropositivity according to age group of subjects  
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Discussion 
 
The seroprevalence rate of 30.9% obtained in this sudy 
is high and suggests that H. pylori infection is signifi-
cant in the paediatric age group of the study locality. 
This is consistent with high prevalence rates reported 
among children in other developing countries.5-9, 15, 17 
Symptoms which were associated with H. pylori sero-
positivity included abdominal pains, fetor oris and diar-
rhoea. 
 
The association of abdominal pains with H. pylori sero-
positivity has also been reported by other authors.19,20  
This could be as a result of gastritis which has been re-
ported to develop rapidly after acquisition of the infec-
tion and remains with the persistence of the infection.10  
Malatyet al 19 reported that the younger children who 
had recurrent abdominal pains were more likely than 
older children, to be infected with H. pylori. Also, in a 
forty year review article by Bittencourtet al,20 it was 
stated that in the under-seven years old school children, 
abdominal pain was described in virtually all cases of H. 
pylori infection. These reports are comparable with our 
findings of higher occurrence of abdominal pain in the  
five -10 year olds. 
 
Data from this study showed a significant association 
between diarrhoea and H. pylori seropositivity. Some 
other studies had also suggested that infection with H. 
pylori may predispose patients to other gastrointestinal 
infections. Passaroet al 21 reported that newly acquired 
H. pylori infection was followed with increased occur-
rence of diarrhoea. In contrast, the study by Rothen-
bacheret al 22 reported a significantly less occurrence of 
acute diarrhoeal illness in H. pylori infected children and 
adults, compared to uninfected subjects. It is difficult to 
exclude other confounding factors which may explain 
the conflicting reports of these observational studies. 
 
The significance of etor oris  as seen in this study was 
also reported in the voluntary experimental ingestion of 
a pure culture of H. pylori by Marshall.23 This symptom 
among others, was noted to have resolved completely 
within twenty four hours of the start of therapy with 
Tinidazole (500mg twice a day), for eradication of H. 
pylori.20  
The production of ammonia from urea by H.  pylori 
which is a urease splitting organism has been docu-
mented to be the likely physiological basis of fetor oris 
in H. pylori infection.24 
 
There was no association between H. pylori seropositiv-
ity and the weight, height and body mass index of these 
subjects. The relationship of growth parameters and H. 
pylori infection in children as reported in previous stud-
ies has not showed a consistent pattern. The lack of as-
sociation as seen in this study was also reported by 
Oderdaet al.25 Their study did not show any risk for 
short stature in H. pylori  infected children after control-
ling for the socioeconomic status of their families. In 
contrast, Chloe et al.26 reported a significantly lower 
mean height in H. pylori infected school children in 






The IgG seropositvity rate in our study population is 
high and shows positive association with clinical fea-
tures such as fetor oris,  abdominal pain and diarrhoea, 
as well as with a positive family history of dyspepsia.  
We recommend that children presenting with any com-
bination of these features should be screened for H. py-
lori  infection as early confirmation of infection in child-
hood with appropriate eradication therapy will impact 
positively on the reduction or prevention of long term 
sequelae of this treatable bacterial infection. 
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